Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Verastem (VSTM) Receivables (2018 - 2025)

Verastem has reported Receivables over the past 8 years, most recently at $8.8 million for Q4 2025.

  • Quarterly results put Receivables at $8.8 million for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $8.8 million (changed N/A YoY), and the annual figure for FY2025 was $8.8 million, changed.
  • Receivables for Q4 2025 was $8.8 million at Verastem, up from $6.7 million in the prior quarter.
  • Over the last five years, Receivables for VSTM hit a ceiling of $10.0 million in Q2 2024 and a floor of $64000.0 in Q2 2023.
  • Median Receivables over the past 5 years was $686000.0 (2021), compared with a mean of $2.6 million.
  • Biggest five-year swings in Receivables: tumbled 95.87% in 2021 and later surged 15525.0% in 2024.
  • Verastem's Receivables stood at $686000.0 in 2021, then plummeted by 81.49% to $127000.0 in 2022, then crashed by 49.61% to $64000.0 in 2023, then surged by 15525.0% to $10.0 million in 2024, then dropped by 11.87% to $8.8 million in 2025.
  • The last three reported values for Receivables were $8.8 million (Q4 2025), $6.7 million (Q3 2025), and $2.1 million (Q2 2025) per Business Quant data.